Table 1. Clinical and Demographic Characteristics of the Study Cohort At Study Entry.

Measure	Median	IQR	N
Log10 HIV-1 RNA c/mL	4.3	(3.6, 4.9)	177
CD4+ T cell counts/uL	535	(409, 698)	184
Age (Years)	30.8	(24.7, 36.3)	186
Clinical Follow-Up
Observation Time (Days)	389	(117, 833)	186
Total Person Days (Sum)	96466		186
Time Until ART Started (Days)*	381	(129.5, 649)	49

^*Anti Hepatitis B Core Antibody.